lobbying_activities: 2684661

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2684661	89c7f8ed-ccb8-495e-ace3-869d045caf65	Q3	BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC	401104621	BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC	2021	third_quarter	INS	HR 1629, S250 Fairness in Orphan Drug Exclusivity Act; Administration of controlled substances by HCPs; Storage of controlled substances	HOUSE OF REPRESENTATIVES,SENATE,White House Office		100000	0	0	2021-10-18T12:03:00.890000-04:00